Greg Bourne has a wealth of experience in the field of chemistry, holding various roles ranging from Research Officer to VP Chemistry at Protagonist Therapeutics. Greg has also worked at esteemed institutions such as Washington University in St. Louis and the Institute for Molecular Bioscience. Greg holds a Ph.D. in Medicinal Chemistry from the University of Cambridge and a Graduate Dip. in Applied Investment and Finance from the Securities Institute of Australia.
March 1, 2024 - present
January, 2023
July, 2022
February, 2021
March, 2016
January, 2014
January, 2007